The Global Companion Diagnostics Market was valued at USD 7.66 billion in 2023 and is projected to reach USD 21.15 billion by 2032, growing at a compound annual growth rate (CAGR) of 11.9% over the forecast period from 2024 to 2032. The increasing adoption of precision medicine, advancements in biomarker identification, and a rising focus on targeted...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian